Teva Pharmaceutical Industries Ltd. — Earnings Release 2015

Apr 19, 2015

_________ false

C002��� ������ ��������� ��"�2PublicTEVA- PHARMACEUTICAL INDUSTRIES LTD10205Corporation no: 520013954Stock Exchange/Market: NYSE310380P.O.B 3190 , Petach Tikva 49131 , ,Tel: 03-9267267 , 03-9267652 Fax: 03-9267519E.mail address: tomer.amitai@teva.co.ilReported via MAGNA: 19/04/2015              Time of broadcast: 09:42 09:40:45

Reference: 2015-02-001377

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on Teva to Report First Quarter 2015 Financial Results on April 30, 2015
Q1_2015_Earnings_Announcement_ENG-HEB_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 15/04/2015
- - -
Name of the Signatory: : Bergwerk Dov , Position of Signatory in the reporting corporation: Vice President & General Counsel , Name of Employer Company: .
Basel Telephone: 03-9267513 , Facsimile: 03-9267429 , E-mail: einat.barzilai@teva.co.il 1